Compile Data Set for Download or QSAR
maximum 50k data
Found 42 Enz. Inhib. hit(s) with all data for entry = 6542
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138145(US8877967, 11)
Affinity DataIC50:  8.12nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138142(US8877967, 3)
Affinity DataIC50:  10.5nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138142(US8877967, 3)
Affinity DataIC50:  17.4nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138143(US8877967, 6)
Affinity DataIC50:  23.8nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138146(US8877967, 13)
Affinity DataIC50:  24.3nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138154(US8877967, 25)
Affinity DataIC50:  25nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138150(US8877967, 33)
Affinity DataIC50:  587nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138144(US8877967, 9)
Affinity DataIC50:  1.03E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138150(US8877967, 33)
Affinity DataIC50:  2.11E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138154(US8877967, 25)
Affinity DataIC50:  2.80E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138149(US8877967, 17)
Affinity DataIC50:  3.20E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138148(US8877967, 18)
Affinity DataIC50:  3.20E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138147(US8877967, 19)
Affinity DataIC50:  3.20E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138149(US8877967, 17)
Affinity DataIC50:  6.16E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138147(US8877967, 19)
Affinity DataIC50:  6.16E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138148(US8877967, 18)
Affinity DataIC50:  6.16E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138144(US8877967, 9)
Affinity DataIC50:  7.82E+3nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138146(US8877967, 13)
Affinity DataIC50:  8.50E+3nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138151(US8877967, 22)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138150(US8877967, 33)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138153(US8877967, 24)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138149(US8877967, 17)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138147(US8877967, 19)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138149(US8877967, 17)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138152(US8877967, 23)
Affinity DataIC50: >1.00E+4nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin K(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138153(US8877967, 24)
Affinity DataIC50: >1.00E+4nMpH: 3.5 T: 2°CAssay Description:Recombinant human procathepsin K was obtained from Enzo Life Sciences. Activation of the proenzyme was performed in 32.5 mM sodium acetate pH 3.5, ED...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138148(US8877967, 18)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138142(US8877967, 3)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138143(US8877967, 6)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138145(US8877967, 11)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138146(US8877967, 13)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138148(US8877967, 18)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138149(US8877967, 17)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138147(US8877967, 19)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138149(US8877967, 17)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138148(US8877967, 18)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCathepsin B(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138147(US8877967, 19)
Affinity DataIC50: >1.00E+4nMpH: 6.0Assay Description:Human liver Cathepsin B (Calbiochem) was pre-incubated with test compound at various concentrations for 5 minutes at 37C. The assay was initiated by ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138151(US8877967, 22)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138152(US8877967, 23)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138153(US8877967, 24)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138147(US8877967, 19)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetProcathepsin L(Homo sapiens (Human))
Oxigene

US Patent
LigandPNGBDBM138148(US8877967, 18)
Affinity DataIC50: >1.00E+4nMpH: 5.5Assay Description:Human liver Cathepsin L (Sigma) was preincubated with test compounds at various concentrations for 5 minutes at 25C. The assay was initiated by addit...More data for this Ligand-Target Pair
In DepthDetails US Patent